Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1997-10-7
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0022-3050
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
63
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
273-4
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9285479-Aged,
pubmed-meshheading:9285479-Alleles,
pubmed-meshheading:9285479-Alzheimer Disease,
pubmed-meshheading:9285479-Apolipoproteins E,
pubmed-meshheading:9285479-Cognition Disorders,
pubmed-meshheading:9285479-Female,
pubmed-meshheading:9285479-Humans,
pubmed-meshheading:9285479-Male
|
pubmed:year |
1997
|
pubmed:articleTitle |
Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease.
|
pubmed:publicationType |
Letter,
Comment
|